In Q3 2026, we analyzed 4,010 ChatGPT recommendations across 13 tech hardware and device categories to compile the AI Visibility Index.

AI recommendations for tech hardware and devices are becoming more selective, with fewer brands and sources breaking through. Our Q3 2026 index tracks visibility in 13 categories across the industry.

Oura pauses its public debut. Tough market conditions could sharpen questions about its valuation and room to expand.

Diagnostic delays and dismissed symptoms leave room for better care and patient tools.

Health wearables have moved past step counting. They now offer personalized coaching, advanced health monitoring, and 24/7 conversational support. The technology is advancing faster than the answers to the questions it raises: whether the data is reliable, who can afford the devices, and whether doctors want the information at all. Modern devices now track complex health metrics including electrocardiograms to detect irregular heart rhythms, blood oxygen levels, skin temperature, heart rate variability, and stress levels. That is far beyond the basic step counting of earlier generations. "Wearables, of course, have been around for a while, but they're really having a moment this year," said our analyst Rajiv Leventhal on a recent episode of "Behind the Numbers."

Apple's large health app user base and no added subscription for most new health features could give it an edge over rivals with similar offerings.

Oura's health platform ambitions as outlined in its IPO filing could widen revenues, provided medical and wellness partners trust its data and guidance.

Whoop will offer advanced lab testing to more non-members, risking a low-margin standalone business if they don’t convert to wearable customers.

GLP-1s are creating a new consumer economy that reaches beyond healthcare. As treatment becomes easier to access, brands must balance growth opportunities with misinformation, fragmented support, and rising expectations for lifestyle services.

Wearables are shifting from fitness trackers to connected healthcare platforms. The value of AI, clinician access, and health data integration is expanding, as high costs risk excluding consumers who need these tools the most.

Reaching patients through insurers and providers could unlock wearable adoption among higher-need cohorts and strengthen long-term loyalty.

In June 2026, we analyzed 4,010 ChatGPT recommendations across 13 categories in the tech hardware and devices industry to compile the AI Visibility Index.

Oura courts GLP-1 users with free ring sizing kit via Lilly tie-up, signaling how drugmakers are pairing therapies with digital health tools to boost engagement and long-term adherence.

Oura's smart ring adds blood pressure signals, health records, and clinician chat—further blurring the line between wellness tools and healthcare tools.

Google Health app will use device data and medical records to deliver health insights, intensifying competition among consumer health wearables and AI tools.

A $10.1 billion valuation fuels its AI-driven health ambitions as Apple, Oura, and Fitbit ramp up rival features.

Maven Clinic’s agentic AI service meets rising demand by women for more personalized tools and raises the bar for brands in AI-assisted healthcare.

Most consumers give health apps a try, but just 3% stay after 30 days. AI features may be the fix, but only if brands don't overhype their value.

Health apps are mainstream, but brands are having trouble keeping users engaged. Actionable, value-added AI features will be essential for many health apps to stay relevant.